Fig. 1. Overview of the process followed in this study to retrieve and review breast cancer VUS identified from FCC clinical databases for unrecognised actionability, and to understand processes limiting VUS review and reclassification.

ACMG/AMP American College of Medical Genetics and Genomics/Association for Molecular Pathology, FCC Familial cancer centre, VUS Variant of uncertain significance.